{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:20:58Z","timestamp":1785511258303,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.clindermatol.2009.06.018","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T07:03:08Z","timestamp":1276239788000},"page":"337-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Lo Schiavo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Valentina","family":"Puca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2009.06.018_bib1","first-page":"113","article-title":"Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory","volume":"16","author":"Schmidt","year":"2000","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib2","first-page":"299","article-title":"Pemphigus and environmental factors","volume":"138","author":"Ruocco","year":"2003","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.det.2004.09.006","article-title":"The use of systemic immune moderators in dermatology: an update","volume":"23","author":"Kazlow Stern","year":"2005","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0733-8635(05)70006-1","article-title":"Immunosuppressive agents in dermatology. An update","volume":"16","author":"Dutz","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0190-9622(99)70203-3","article-title":"Mycophenolate mofetil in autoimmune and inflammatory skin disorders","volume":"40","author":"Nousari","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(00)90014-8","article-title":"The use of chlorambucil with prednisone in the treatment of pemphigus","volume":"42","author":"Shah","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2133.2004.06241.x","article-title":"Chlorambucil as a steroid-sparing agent in bullous pemphigoid","volume":"151","author":"Chave","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","article-title":"Rituximab in treatment-resistant autoimmune blistering skin disorders","volume":"34","author":"Schmidt","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clindermatol.2004.06.015","article-title":"Life-threatening bullous dermatoses: Pemphigus vulgaris","volume":"23","author":"Ruocco","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2230.1995.tb01327.x","article-title":"Management of the immunobullous disorders. II. Pemphigus","volume":"20","author":"Huilgol","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/archderm.1992.01680210040004","article-title":"Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy","volume":"128","author":"Hymes","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib16","first-page":"105","article-title":"Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone","volume":"63","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-4632.2007.03225.x","article-title":"Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone","volume":"46","author":"Nanda","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-4632.2008.03444.x","article-title":"Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab","volume":"47","author":"Meijs","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.2005.01345.x","article-title":"Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature","volume":"20","author":"Barnadas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7819-6-83","article-title":"Paraneoplastic pemphigus regression after thymoma resection","volume":"6","author":"Barbetakis","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib22","first-page":"495","article-title":"Bullous pemphigoid, an autoimmune blistering disease with protean clinical manifestations. Review of recent advances from the bench to the bedside","volume":"141","author":"Lebeau","year":"2006","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1542-0124(12)70281-1","article-title":"Ocular mucous membrane pemphigoid: diagnosis and management strategies","volume":"6","author":"Saw","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.142.11.1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0738-081X(91)90030-O","article-title":"Linear IgA bullous dermatosis of adults","volume":"9","author":"Chorzelski","year":"1991","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2230.1997.tb02627.x","article-title":"Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole","volume":"22","author":"Pulimood","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2230.2005.01741.x","article-title":"Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent","volume":"30","author":"Talhari","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tripleo.2006.09.019","article-title":"Successful treatment of oral linear IgA disease using mycophenolate","volume":"103","author":"Lewis","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archderm.139.9.1121","article-title":"Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil","volume":"139","author":"Farley-Li","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1046\/j.1365-2133.2003.05537.x","article-title":"Successful treatment of linear IgA disease with salazosulphapyridine and intravenous immunoglobulins","volume":"149","author":"Goebeler","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000106585","article-title":"Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab","volume":"215","author":"Wallet-Faber","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2007.08048.x","article-title":"Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab","volume":"157","author":"Sadler","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2006.07596.x","article-title":"A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita","volume":"156","author":"Crichlow","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0151-9638(07)78256-X","article-title":"Autre immunosuppresseurs: azathioprine (Imurel\u00ae), mycoph\u00e9nolate mof\u00e9til (Cellcept\u00ae), cyclophosphamide (Endoxan\u00ae)","volume":"134","author":"Gaudy-Marqueste","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09546630701449080","article-title":"The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris","volume":"18","author":"Momeni","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1346-8138.2004.tb00571.x","article-title":"A case of refractory bullous pemphigoid with plasmapheresis-associated thrombopenia: efficacy of pulsed intravenous cyclophosphamide therapy","volume":"31","author":"Ogawa","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archderm.1997.03890380119026","article-title":"Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide","volume":"133","author":"Pandya","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2133.2005.06826.x","article-title":"Mucous membrane pemphigoid: management of advanced ocular disease with intravenous cyclophosphamide and amniotic membrane transplantation","volume":"153","author":"Yesudian","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1997.d01-1198.x","article-title":"Azathioprine in dermatology: a survey of current practice in the U.K","volume":"136","author":"Tan","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0151-9638(07)78253-4","article-title":"Ciclosporine: N\u00e9oral\u00ae, Sandimmun\u00ae","volume":"134","author":"Doutre","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib42","first-page":"363","article-title":"Current treatment of pemphigus","volume":"142","author":"Benoit","year":"2007","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(08)80866-3","article-title":"Topical cyclosporine for cicatricial pemphigoid","volume":"28","author":"Aza\u00f1a","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","article-title":"Topical cyclosporin A in the treatment of anterior segment inflammatory disease","volume":"12","author":"Holland","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.144.6.783","article-title":"Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?","volume":"144","author":"Lehman","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0151-9638(07)78259-5","article-title":"Rituximab: Mabthera\u00ae","volume":"134","author":"Lapeyre","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil","volume":"139","author":"Mimouni","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09546630600964999","article-title":"Treatment of refractory blistering autoimmune diseases with mycophenolic acid","volume":"17","author":"Marzano","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00128071-200708020-00004","article-title":"Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris","volume":"8","author":"Olszewska","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.06.018_bib53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:23Z","timestamp":1760033663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X09001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0738081X09001515"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.06.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}